Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01859819
Title Treatment for Advanced B-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York Medical College
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

Burkitt lymphoma

Therapies

Cytarabine + Rituximab

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.